Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Schwarzböck, Alice"'
Autor:
Monteil, Vanessa, Eaton, Brett, Postnikova, Elena, Murphy, Michael, Braunsfeld, Benedict, Crozier, Ian, Kricek, Franz, Niederhöfer, Janine, Schwarzböck, Alice, Breid, Helene, Devignot, Stephanie, Klingström, Jonas, Thålin, Charlotte, Kellner, Max J, Christ, Wanda, Havervall, Sebastian, Mereiter, Stefan, Knapp, Sylvia, Sanchez Jimenez, Anna, Bugajska‐Schretter, Agnes, Dohnal, Alexander, Ruf, Christine, Gugenberger, Romana, Hagelkruys, Astrid, Montserrat, Nuria, Kozieradzki, Ivona, Hasan Ali, Omar, Stadlmann, Johannes, Holbrook, Michael R, Schmaljohn, Connie, Oostenbrink, Chris, Shoemaker, Robert H, Mirazimi, Ali, Wirnsberger, Gerald, Penninger, Josef M
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
EMBO Mol Med.
Dipòsit Digital de la UB
Universidad de Barcelona
article-version (status) pre
article-version (number) 1
EMBO Mol Med.
Dipòsit Digital de la UB
Universidad de Barcelona
The recent emergence of multiple SARS-CoV-2 variants has caused considerable concern due to reduced vaccine efficacy and escape from neutralizing antibody therapeutics. It is therefore paramount to develop therapeutic strategies that inhibit all know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70de52e686744328648861546d422fbe
http://hdl.handle.net/2445/187538
http://hdl.handle.net/2445/187538
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Monteil V; Unit of Clinical Microbiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Eaton B; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, Maryland, USA., Postnikova E; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, Maryland, USA., Murphy M; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, Maryland, USA., Braunsfeld B; Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria., Crozier I; Clinical Research Monitoring Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Kricek F; NBS-C BioScience & Consulting GmbH, Vienna, Austria., Niederhöfer J; invIOs, Vienna, Austria., Schwarzböck A; invIOs, Vienna, Austria., Breid H; invIOs, Vienna, Austria., Devignot S; Unit of Clinical Microbiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Klingström J; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Thålin C; Department of Clinical Sciences, Karolinska Institute Danderyd Hospital, Stockholm, Sweden., Kellner MJ; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical, University of Vienna, Vienna, Austria., Christ W; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Havervall S; Department of Clinical Sciences, Karolinska Institute Danderyd Hospital, Stockholm, Sweden., Mereiter S; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Knapp S; Department of Medicine 1, Laboratory of Infection Biology, Medical University of Vienna, Vienna, Austria., Sanchez Jimenez A; invIOs, Vienna, Austria., Bugajska-Schretter A; invIOs, Vienna, Austria., Dohnal A; invIOs, Vienna, Austria., Ruf C; NBS-C BioScience & Consulting GmbH, Vienna, Austria., Gugenberger R; invIOs, Vienna, Austria., Hagelkruys A; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Montserrat N; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain., Kozieradzki I; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada., Hasan Ali O; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada., Stadlmann J; Institute of Biochemistry, Department of Chemistry, University of Natural resources and Life, Sciences (BOKU), Vienna, Austria., Holbrook MR; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, Maryland, USA., Schmaljohn C; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, Maryland, USA., Oostenbrink C; Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria., Shoemaker RH; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Mirazimi A; Unit of Clinical Microbiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Wirnsberger G; invIOs, Vienna, Austria., Penninger JM; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2022 Aug 08; Vol. 14 (8), pp. e15230. Date of Electronic Publication: 2022 Jul 04.
Autor:
Wirnsberger G; Apeiron Biologics, Vienna, Austria., Monteil V; Karolinska Institutet and Karolinska University Hospital, Unit of Clinical Microbiology, SE-17182, Stockholm, Sweden., Eaton B; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA., Postnikova E; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA., Murphy M; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA., Braunsfeld B; Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU), Austria., Crozier I; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA., Kricek F; NBS-C BioScience & Consulting GmbH, Vienna, Austria., Niederhöfer J; Apeiron Biologics, Vienna, Austria., Schwarzböck A; Apeiron Biologics, Vienna, Austria., Breid H; Apeiron Biologics, Vienna, Austria., Jimenez AS; Apeiron Biologics, Vienna, Austria., Bugajska-Schretter A; Apeiron Biologics, Vienna, Austria., Dohnal A; Apeiron Biologics, Vienna, Austria., Ruf C; NBS-C BioScience & Consulting GmbH, Vienna, Austria., Gugenberger R; Apeiron Biologics, Vienna, Austria., Hagelkruys A; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Montserrat N; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain., Holbrook MR; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA., Oostenbrink C; Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU), Austria., Shoemaker RH; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892., Mirazimi A; Karolinska Institutet and Karolinska University Hospital, Unit of Clinical Microbiology, SE-17182, Stockholm, Sweden., Penninger JM; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2021 Sep 10. Date of Electronic Publication: 2021 Sep 10.